Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review.

Biologics · 2026 · PMC13050157 · PMID 41938822

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In Chung et al (2021), compared to the low-dose group, the medium- and high-dose groups exhibited a slower rate of increase in UMSARS Part II (group × time, p = 0.131) and total scores (group × time, p = 0.096); these trends did not reach statistical significance due to the small number of patients in each group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.